Ozempic side effects: what to expect and when to get help
Published 20 August 2026 · Updated 20 August 2026
The most common Ozempic side effects are digestive: nausea, diarrhoea, vomiting and constipation. In the placebo-controlled trials on the US label, nausea affected 15.8% of people on the 0.5 mg dose and 20.3% on 1 mg, most cases were mild to moderate, and they clustered around dose increases.
Ozempic is the brand name for semaglutide, a once-weekly injection registered with SAHPRA for type 2 diabetes, not for weight loss. It is a Schedule 4 medicine, so treatment always starts with a doctor's assessment and authorisation, and the side effects below are part of what that assessment weighs.
This guide covers the common effects and their usual timeline, the rare ones that need urgent care, who should not use semaglutide at all, and when a symptom means talking to your doctor rather than pushing through.
What are the most common Ozempic side effects?
Digestive effects lead by a wide margin: nausea, diarrhoea, vomiting and constipation, with abdominal pain, burping and reflux close behind. In the placebo-controlled diabetes trials on the US label, roughly a third of people on Ozempic reported at least one digestive side effect, against 15.3% on placebo.
| Side effect | Ozempic 0.5 mg | Ozempic 1 mg | Placebo |
|---|---|---|---|
| Nausea | 15.8% | 20.3% | 6.1% |
| Diarrhoea | 8.5% | 8.8% | 1.9% |
| Abdominal pain | 7.3% | 5.7% | 4.6% |
| Vomiting | 5.0% | 9.2% | 2.3% |
| Constipation | 5.0% | 3.1% | 1.5% |
| Any digestive effect | 32.7% | 36.4% | 15.3% |
Two patterns in that table matter. Rates rise with dose, and the placebo groups reported some of the same complaints, so not every queasy day belongs to the pen. In the same trials, 3.1% to 3.8% of participants stopped treatment because of digestive effects. Individual results vary.
At the higher 2.4 mg semaglutide dose registered for weight management under the brand Wegovy, the same effects appear more often: nausea affected 44% of participants in the STEP 1 trial. Reduced appetite, tiredness, headache and mild injection-site redness round out the common list at every dose.
When do Ozempic side effects start and how long do they last?
Side effects track dose changes, not the calendar. Most digestive effects appear in the first days to weeks on a new strength and fade as the body adjusts. In semaglutide trial data, the median bout of nausea lasted 8 days, diarrhoea 3 days and vomiting 2 days.
The label makes the same point in one line: the majority of nausea, vomiting and diarrhoea reports came during dose escalation. Each step up the ladder can restart a milder version of the cycle, which is why the first month on any new strength is the stretch to watch.
Constipation is the outlier. It builds slowly, resolves slowly, and responds better to prevention than to rescue, so the water and fibre habit belongs at the start of treatment rather than after trouble arrives.
A symptom that persists for weeks without easing, or that returns and worsens after it had settled, breaks the expected pattern. That is a signal to contact your doctor rather than wait for the next scheduled review.
Why does Ozempic cause nausea?
Because slowing digestion is part of how semaglutide works. It mimics GLP-1, a natural gut hormone, which slows stomach emptying and turns down appetite signalling in the brain. Food sits longer, you fill up sooner, and nausea, fullness and burping are that mechanism overshooting, not a sign of damage.
The same pathway explains the dose pattern. Each increase asks the digestive system to adjust again, so symptoms flare around the step and settle once the body catches up. It also explains the single most reliable trigger: a large, fatty meal landing on a stomach that empties more slowly than it used to.
The benefit and the discomfort come from one mechanism, which is why the goal of treatment is not zero sensation. Doctors look for the dose where appetite control is doing its work and the digestive effects stay manageable, and for most people in the trials that balance existed.
How does the Ozempic dose schedule affect side effects?
The schedule is built to limit them. Treatment starts at 0.25 mg weekly for four weeks, an adjustment dose too low to control blood sugar on its own, then moves to 0.5 mg. Only if more effect is needed, and the current dose is tolerated, does a doctor step up further.
The two pen presentations registered in South Africa deliver weekly doses from 0.25 mg up to 1 mg. Every step up moves you through the same adjustment cycle, so the pace matters more than the destination.
There is no obligation to climb on schedule. Doctors routinely hold a dose for extra weeks until the gut settles, or drop back a step after a rough patch. That is standard care, not a failure, and there is no clinical prize for reaching the highest strength.
One schedule rule is worth memorising: a missed dose can be taken up to five days late, and after that the advice is to skip it and stay on your usual injection day. Never inject two doses to catch up; when in doubt, ask your doctor or pharmacist.
How do you manage Ozempic side effects at home?
Mostly with food and fluid tactics. Smaller meals eaten slowly, lower-fat food in dose-increase weeks, and stopping at the first signal of fullness prevent most nausea. Water comes first for constipation, and an oral rehydration solution from any pharmacy covers diarrhoea days better than plain water does.
Small habits carry surprising weight. Stay upright for an hour after eating. Keep cold water, ginger or peppermint tea within reach on dose-change weeks. Inject on the same day each week, and pick a day where a rough 24 hours costs you least, since symptoms often peak the day after a dose.
Rotate injection sites between stomach, thigh and upper arm to limit skin irritation, and keep unused pens in the fridge as the packaging directs. What you eat shapes most of the rest, and what to eat on GLP-1 medication turns these principles into an actual plate.
Since the digestive playbook is shared across this class of medicine, managing GLP-1 side effects goes deeper on remedies and timing. If home measures are not holding a symptom down, message your doctor: a longer hold at the current dose usually fixes what willpower cannot.
Which Ozempic side effects are serious?
A short list, and each is rare. Acute pancreatitis, gallbladder disease, severe dehydration, serious allergic reactions and a rare eye condition called NAION. The warning sign that matters most is severe, persistent stomach pain, especially pain radiating to the back: stop injecting and seek medical care immediately.
Pancreatitis is the reason regulators keep updating this class. In January 2026 the UK regulator MHRA strengthened the warnings for all GLP-1 medicines, noting that acute pancreatitis stays uncommon but can be severe, with rare necrotising and fatal cases on record. If pancreatitis is confirmed, the medicine is stopped and not restarted.
Gallbladder problems occur somewhat more often on this class, partly through rapid weight loss itself. Pain under the right ribs, fever or yellowing skin needs prompt medical attention. Vomiting that will not stop needs urgent care too, because severe dehydration can injure the kidneys: if you cannot keep fluids down, seek medical care immediately.
In February 2026 the MHRA put a number on NAION, a sudden loss of vision in one eye: about one extra case for every 10,000 people using semaglutide for a year. Sudden vision loss, even partial, means seek medical care immediately. The same urgency applies to any sign of a serious allergic reaction, such as swelling of the face or throat or difficulty breathing.
Low blood sugar deserves a separate line: it is uncommon on semaglutide alone but becomes a real risk when combined with insulin or a sulfonylurea, which is why a doctor reviews every diabetes medicine you take.
Does Ozempic affect your mood or mental health?
No causal link has been found. The European Medicines Agency reviewed reports of low mood and self-harm thoughts across GLP-1 medicines and concluded in April 2024 that the available evidence does not support a link, so no warning was added to the product information.
That conclusion came from clinical trial data, health-record studies and post-marketing reports reviewed together, and regulators continue to monitor the question. It is reassurance about the medicine, not about mood itself.
Mood can shift during any period of major weight change, for reasons that range from eating far less to sleeping differently. Persistent low mood, whatever you suspect the cause is, belongs in front of your doctor, and urgent thoughts of self-harm mean seek medical care immediately.
Who should not use Ozempic?
Some exclusions are firm. Ozempic is not used in pregnancy, while trying to conceive or while breastfeeding, and not by anyone with a personal or family history of medullary thyroid cancer or MEN2 syndrome. A history of pancreatitis, or severe gut disease such as gastroparesis, needs specialist judgement.
Diabetic eye disease needs naming because Ozempic is a diabetes medicine. In the SUSTAIN 6 trial, diabetic retinopathy complications occurred in 3.0% of semaglutide users against 1.8% on placebo, with the risk concentrated in people who had retinopathy already. Anyone in that position needs eye monitoring during treatment.
Type 1 diabetes sits outside the registration entirely, and semaglutide is never a substitute for insulin. Planned surgery is a disclosure moment rather than an exclusion: tell the surgical and anaesthetic team you use it, because a slowed stomach changes fasting requirements.
Finally, list every medicine you take, including tablets that seem unrelated. Slower digestion can shift how some oral medicines are absorbed. Screening for all of this is the point of the doctor's assessment that precedes any treatment plan.
Is Ozempic registered for weight loss in South Africa?
No. SAHPRA has registered Ozempic for type 2 diabetes in adults, and to reduce the risk of major cardiovascular events in adults with diabetes and known heart disease. Semaglutide for chronic weight management is registered under a different brand, Wegovy, at a higher 2.4 mg weekly dose.
That distinction shapes the side-effect numbers too. The rates in the table above describe the diabetes doses; the weight-management dose runs higher, and its digestive effects are more frequent. A doctor may use a registered medicine outside its registered indication at their clinical discretion, but that is a decision made after a full assessment, with the registered weight-management options weighed first.
Where Ozempic fits in South African pharmacies, and how its supply and regulated pricing work, is covered in Ozempic in South Africa: availability and cost.
One warning belongs here. Everything in this article describes the registered product. Compounded, falsified or unregistered products sold as semaglutide have unverified contents, so their side effects cannot be predicted at all, and SAHPRA has warned the public against them repeatedly.
Does Ozempic change your face or body shape?
Not directly. The gaunt look nicknamed Ozempic face, and the deflated shape nicknamed Ozempic butt, are effects of losing weight quickly from any cause: fat volume leaves the face and buttocks, and skin needs time to catch up. The medicine changes appetite; the pace of loss does the rest.
The countermeasures are about pace and composition rather than the pen. A slower rate of loss, enough protein each day and regular strength training preserve more muscle and soften the change. Temporary hair shedding after rapid weight loss follows the same logic and usually regrows once weight stabilises.
What the facial change involves, and what helps once it has happened, is covered in what Ozempic face is and how to avoid it.
How do Ozempic side effects compare with other GLP-1 medicines?
The pattern is shared across the class. Semaglutide, tirzepatide and liraglutide all slow digestion, so the same cluster leads everywhere: nausea, diarrhoea, vomiting and constipation, worst around dose increases. What shifts between medicines is mostly the rates recorded in their trials, which used different doses and designs.
| Medicine and dose | Data source | Nausea reported |
|---|---|---|
| Ozempic 0.5 mg and 1 mg (diabetes doses) | US label, placebo-controlled trials | 15.8% and 20.3% |
| Semaglutide 2.4 mg (Wegovy) | STEP 1 trial, 68 weeks | 44% |
| Tirzepatide (Mounjaro) | SURMOUNT-1 trial, 72 weeks | 24% to 33% by dose |
Read the table as context, not a contest. The figures come from separate trials with different participants, doses and durations, so they do not rank the medicines against each other.
The 2.4 mg semaglutide picture is unpacked in Wegovy side effects, and the tirzepatide figures dose by dose in Mounjaro side effects. If one medicine does not suit you after a fair trial, moving to another in the class is routine, and the right option is decided by a doctor on assessment.
When should you contact a doctor about Ozempic side effects?
Any time a symptom outlasts the dose-adjustment window, interferes with eating and drinking normally, or matches a warning sign in the serious list above. Persistent daily vomiting, dizziness on standing, an inability to finish small meals or weight falling much faster than expected all justify a review.
Most of what gets reported is solved with unglamorous adjustments: a longer hold at the current dose, a slower schedule, treatment for a specific symptom. Structured care builds this in, with a review before each dose change, which is exactly where problems surface and get fixed. How those reviews run in a doctor-led programme is described in what to expect.
South Africans can also report suspected side effects directly to SAHPRA through its Med Safety app or reporting forms, alongside telling their doctor and pharmacist. Those reports feed the monitoring that keeps the registered label current.
Side effects are one side of a ledger. A doctor weighs them against what the medicine is achieving for you, at your dose, in your health picture, and that conversation works best when symptoms are reported early rather than endured.
Frequently asked questions
Does Ozempic make you tired?
Yes, fatigue is a recognised side effect, especially in the early weeks and when eating much less than before. It usually passes; tiredness that persists is worth raising with your doctor.
Can Ozempic cause hair loss?
Temporary hair shedding can follow rapid weight loss from any cause, including semaglutide treatment. It usually regrows once weight stabilises; mention it to your doctor if it continues.
Does Ozempic cause low blood sugar?
Rarely on its own. The risk rises when it is combined with insulin or sulfonylurea diabetes medicine, which is why a doctor reviews everything you take before treatment starts.
Can you drink alcohol on Ozempic?
There is no outright ban, but alcohol sits badly on a slowed stomach and commonly worsens nausea and reflux. In people with diabetes it also adds to the risk of low blood sugar, so ask your doctor what is sensible for you.
Should you stop Ozempic before surgery?
Tell your surgical and anaesthetic team well in advance. Because semaglutide slows stomach emptying, the team decides on fasting rules and whether to pause the medicine.
Can you take anti-nausea medicine with Ozempic?
Sometimes, yes. A doctor or pharmacist can recommend a suitable short-term option. Do not add one on your own, because the better fix is often a slower dose schedule.
Why does Ozempic cause burping?
Slower stomach emptying lets gas build up, so burping, sometimes with a sulphur taste, is a recognised effect. Smaller meals, less fat and slower eating reduce it.
Can Ozempic affect your eyesight?
Rarely. People with diabetic retinopathy need eye monitoring during treatment, and sudden vision loss in one eye is a rare emergency: seek medical care immediately.
Sources
- US FDA: Ozempic (semaglutide) label, adverse reactions in placebo-controlled trials
- MHRA Drug Safety Update: GLP-1 medicines, strengthened warnings on acute pancreatitis (January 2026)
- MHRA Drug Safety Update: Semaglutide and risk of NAION
- Wharton et al., Diabetes, Obesity and Metabolism: Gastrointestinal tolerability of semaglutide 2.4 mg (STEP 1)
- SAHPRA: Semaglutide FAQs and safety warnings
- The Pharmaceutical Journal: EMA finds no link between GLP-1 medicines and suicidal thoughts
This article is general information, not personal medical advice. Treatment decisions are made by a registered doctor on assessment. Individual results vary.
